Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
Title:
Safety of Percutaneous Hepatic Perfusion with Melphalan in Patients with Unresectable Liver Metastases from Ocular Melanoma Using the Delcath Systems’ Second-Generation Hemofiltration System: A Prospective Non-randomized Phase II Trial
Author:
Meijer, T. Susanna Burgmans, Mark C. Fiocco, Marta Geus-Oei, Lioe-Fee de Kapiteijn, Ellen Leede, Eleonora M. de Martini, Christian H. Meer, Rutger W. van der Tijl, Fred G. J. Vahrmeijer, Alexander L.